TAMs suppress CD8+ T cell activation via several major mechanisms: (1) interference of CD8 T cell trafficking to the tumor site; (2) depletion of metabolites essential for T cell proliferation; (3) secretion of anti-inflammatory cytokines; and (4) activation of T cell checkpoint blockade. This evidence concerns the gene CD8A and neoplasm.